Skip to search formSkip to main contentSkip to account menu

KUR-1246

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Aim:  To evaluate the safety of KUR‐1246 as a tocolytic agent, we determined the effects of its constant infusion on efficacy… 
2006
2006
Summary The aim of this study was to assess the cardiovascular effects of KUR-1246 (CAS 194785-31-4, (-)-bis(2-{[(2S)-2-({(2R)-2… 
2005
2005
Objective  To evaluate the safety of KUR‐1246 as a tocolytic agent, we examined the effects of its long term infusion on… 
2005
2005
OBJECTIVE To evaluate the safety of KUR-1246 as a tocolytic agent, we examined the effects of its long term infusion on… 
2002
2002
OBJECTIVE To examine the effects of KUR-1246 on oxytocin-induced uterine contractions, the cardiovascular system, and general… 
2002
2002
OBJECTIVE The aims of this study were (1) to evaluate the usefulness of the new beta2-adrenergic stimulant KUR-1246 as a…